BIO BLAST PHARMA LTD's ticker is ORPN and the CUSIP is M20156101. A total of 13 filers reported holding BIO BLAST PHARMA LTD in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $214,000 | -49.5% | 206,054 | -17.9% | 0.38% | -49.5% |
| Q3 2016 | $424,000 | +5.5% | 250,970 | 0.0% | 0.74% | +471.5% |
| Q2 2016 | $402,000 | -35.7% | 250,970 | 0.0% | 0.13% | -48.8% |
| Q1 2016 | $625,000 | -52.4% | 250,970 | -25.8% | 0.25% | -47.7% |
| Q4 2015 | $1,312,000 | -23.8% | 338,110 | 0.0% | 0.49% | -33.5% |
| Q3 2015 | $1,721,000 | -26.1% | 338,110 | 0.0% | 0.73% | -2.7% |
| Q2 2015 | $2,330,000 | +14.8% | 338,110 | 0.0% | 0.75% | +27.1% |
| Q1 2015 | $2,029,000 | -6.1% | 338,110 | 0.0% | 0.59% | -30.5% |
| Q4 2014 | $2,161,000 | -12.1% | 338,110 | 0.0% | 0.85% | -11.1% |
| Q3 2014 | $2,458,000 | – | 338,110 | – | 0.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 206,054 | $214,000 | 0.38% |
| Anson Funds Management LP | 270,793 | $282,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 660,157 | $687,000 | 0.04% |
| OPPENHEIMER & CO INC | 24,700 | $26,000 | 0.00% |
| UBS Group AG | 4,066 | $4,000 | 0.00% |
| BlackRock Investment Management, LLC | 1,255 | $1,000 | 0.00% |
| Virtu KCG Holdings LLC | 15,032 | $16,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,000 | $1,000 | 0.00% |
| BlackRock Fund Advisors | 16,786 | $17,000 | 0.00% |
| MORGAN STANLEY | 1,026 | $2,000 | 0.00% |